An integrated computational biology approach defines the crucial role of TRIP13 in pancreatic cancer.
Computational biology
Early events of cancer
Integrative Biology
Pancreatic cancer
TRIP13
Transcriptomics
Journal
Computational and structural biotechnology journal
ISSN: 2001-0370
Titre abrégé: Comput Struct Biotechnol J
Pays: Netherlands
ID NLM: 101585369
Informations de publication
Date de publication:
2023
2023
Historique:
received:
11
09
2023
revised:
13
11
2023
accepted:
14
11
2023
medline:
11
12
2023
pubmed:
11
12
2023
entrez:
11
12
2023
Statut:
epublish
Résumé
Pancreatic cancer (PanCa) is one of the most aggressive forms of cancer and its incidence rate is continuously increasing every year. It is expected that by 2030, PanCa will become the 2
Identifiants
pubmed: 38074464
doi: 10.1016/j.csbj.2023.11.029
pii: S2001-0370(23)00444-0
pmc: PMC10709078
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5765-5775Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Cancers (Basel). 2023 Sep 15;15(18):
pubmed: 37760554
PLoS One. 2014 Nov 19;9(11):e113023
pubmed: 25409014
Panminerva Med. 2022 Mar;64(1):56-71
pubmed: 34664484
Protein Sci. 2023 Mar;32(3):e4582
pubmed: 36718848
J Clin Oncol. 2005 Jul 10;23(20):4524-31
pubmed: 16002843
Cancer Cell. 2013 Jan 14;23(1):48-62
pubmed: 23328480
Cancers (Basel). 2021 May 27;13(11):
pubmed: 34071792
Cell Commun Signal. 2023 May 4;21(1):96
pubmed: 37143134
J Evid Based Integr Med. 2023 Jan-Dec;28:2515690X231198315
pubmed: 37654084
J Exp Med. 1965 Sep 1;122(3):467-81
pubmed: 4953873
Comput Struct Biotechnol J. 2023 May 01;21:2845-2857
pubmed: 37216018
Front Mol Biosci. 2021 Jul 07;8:693477
pubmed: 34307457
Genes Dev. 2018 May 1;32(9-10):620-638
pubmed: 29802124
J Adv Res. 2023 Feb 23;:
pubmed: 36828119
Adv Sci (Weinh). 2022 Oct;9(29):e2104291
pubmed: 36031387
Am J Cancer Res. 2018 Mar 01;8(3):332-353
pubmed: 29636993
Cancer Cell Int. 2022 Mar 5;22(1):108
pubmed: 35248028
Lab Med. 2021 Nov 2;52(6):550-557
pubmed: 33900408
Cancers (Basel). 2020 Jun 01;12(6):
pubmed: 32492943
Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):24-36
pubmed: 31152822
Mol Oncol. 2021 Oct;15(10):2634-2671
pubmed: 32981205
Oncotarget. 2017 Apr 18;8(16):26718-26731
pubmed: 28157697
Elife. 2015 Apr 28;4:
pubmed: 25918846
Science. 2020 Sep 11;369(6509):1318-1330
pubmed: 32913098
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560
pubmed: 31114875
Commun Med (Lond). 2023 Jan 20;3(1):10
pubmed: 36670203
Oncol Rev. 2019 Feb 01;13(1):410
pubmed: 31044028
Gastroenterol Res Pract. 2018 Nov 21;2018:8704751
pubmed: 30584422
Trends Cancer. 2019 Jan;5(1):30-45
pubmed: 30616754
Oncol Rep. 2023 May;49(5):
pubmed: 36896765
Cancer Res. 2020 Feb 1;80(3):536-548
pubmed: 31732653
Transl Oncol. 2023 Jul;33:101686
pubmed: 37182508
Cancer Metab. 2020 Oct 4;8:12
pubmed: 33020720
Ann Surg Oncol. 2018 Nov;25(12):3483-3491
pubmed: 29786131
Mol Oncol. 2022 Apr;16(8):1728-1745
pubmed: 35194944
Comput Struct Biotechnol J. 2019 Jun 22;17:854-861
pubmed: 31321001
Bioinformatics. 2003 Jan;19(1):163-4
pubmed: 12499312
Metabolites. 2023 Jul 22;13(7):
pubmed: 37512579
Nucleic Acids Res. 2018 Jan 4;46(D1):D956-D963
pubmed: 29136207